Many of the nanotechnology inventions submitted to the Nanocommercialization Group (NCG) may be at too early a stage for licensing or investment consideration.
With that in mind, the Program to Support Translational Research (PSTR) fund provides financial support to characterize, advance the development, demonstrate the commercial potential of, or otherwise increase the commercial value of such inventions.
To be considered for funding, the intellectual property must be approved by the NCG. Consideration for funding is based on assessment of the following:
- Commercial potential
- Technical merit
- Patent protection
- Likelihood of achieving objectives with the resources provided
- Ability of the funded studies to add significant value to the technology and/or to significantly improve its attractiveness for licensing or investment
Click here for information about IP and Licensing through the NCG.
For more information, contact:
Erli Chen, Ph.D.
University of Pennsylvania
Director, Nanotechnology Commercialization Group
Nanotechnology Commercialization in Pennsylvania
“Across the world, the competition to find the next great scientific advancement continues to grow… as a competitor in the global marketplace, it is Pennsylvania’s responsibility to give our universities, companies and partners the best opportunties to be on the forefront of these advancements.”
–The Honorable Edward G. Rendell
Governor of Pennsylvania